Funding {4}
Open Access funding enabled and organized by Projekt DEAL. Funding for this trial has been provided by the independent and non-profit Bristol Myers Squibb-Stiftung Immunonkologie (immune-oncology foundation), Munich. This funding source had no influence on the design of the study and will not have any role during its execution, analyses, or interpretation of the data, as well as in decisions to submit results.